Others publications
Telomeres and telomerase as targets for anticancer drug development.
Olaussen KA, Dubrana K, Domont J, Spano JP, Sabatier L, Soria JC
Crit Rev Oncol Hematol. 57(3):191-214
2006
Spontaneous rDNA copy number variation modulates Sir2 levels and epigenetic gene silencing.
Michel AH, Kornmann B, Dubrana K, Shore D
Genes Dev. 19(10):1199-210
2005
Epigenetic control of chromosome breakage at the 5' end of Paramecium tetraurelia gene A
Amar L.C. and Dubrana K.
Eukaryot Cell. 3(5):1136-46
2004
Live Imaging of Telomeres. yKu and Sir Proteins Define Redundant Telomere-Anchoring Pathways in Yeast.
Hediger F., Neumann F. R., Van Houwe G., Dubrana K. and Gasser S. M.
Curr Biol. 12(24):2076-89
2002
Myosin-like proteins 1 and 2 are not required for silencing or telomere anchoring, but act in the Tel1 pathway of telomere length control.
Hediger F., Dubrana K. and Gasser S. M.
J Struct Biol. 140(1):79-91
2002
Turning telomeres off and on.
Dubrana K., Perrod S. and Gasser S. M.
Curr Opin Cell Biol. 13(3):281-9
2001
Ku deficient strains exhibit alternative states of silencing competence.
Maillet L., Gaden F., Brevet V., Fourel G., Dubrana K., Martin S. G., Gasser S. M. and Gilson E.
EMBO reports, 21 (3), 203-210
2001
Control of DNA excision efficiency in Paramecium.
Dubrana K. and Amar L.C.
Nucleic Acids Res. 29(22):4654-62
2001
Programmed DNA under-amplification in Paramecium primaurelia.
Dubrana K. and Amar L.C.
Chromosoma, 109, 460-466.
2000
Deletion endpoint allele-specificity in the developmentally regulated elimination of an internal DNA sequence (IESs) in Paramecium.
Dubrana K., Le Mouel A.and Amar L.C.
Nucl. Acids Res., 25 (12), 2448-2454
1997
Sequence-specific effects of the maternal somatic genome on developmental rearrangements in Paramecium primaurelia.
Meyer E., Butler A., Dubrana K., Duharcourt S. and Caron F.
Mol. Cell. Biol., 17 (7), 3589-3599.
1997